Literature DB >> 31055118

Chronic kidney disease and aging differentially diminish bone material and microarchitecture in C57Bl/6 mice.

Chelsea M Heveran1, Charles A Schurman2, Claire Acevedo3, Eric W Livingston4, Danielle Howe5, Eric G Schaible6, Heather B Hunt7, Adam Rauff8, Eve Donnelly7, R Dana Carpenter9, Moshe Levi10, Anthony G Lau5, Ted A Bateman4, Tamara Alliston2, Karen B King11, Virginia L Ferguson12.   

Abstract

Chronic kidney disease (CKD) is a common disease of aging and increases fracture risk over advanced age alone. Aging and CKD differently impair bone turnover and mineralization. We thus hypothesize that the loss of bone quality would be greatest with the combination of advanced age and CKD. We evaluated bone from young adult (6 mo.), middle-age (18 mo.), and old (24 mo.) male C57Bl/6 mice three months following either 5/6th nephrectomy, to induce CKD, or Sham procedures. CKD exacerbated losses of cortical and trabecular microarchitecture associated with aging. Aging and CKD each resulted in thinner, more porous cortices and fewer and thinner trabeculae. Bone material quality was also reduced with CKD, and these changes to bone material were distinct from those due to age. Aging reduced whole-bone flexural strength and modulus, micrometer-scale nanoindentation modulus, and nanometer-scale tissue and collagen strain (small-angle x-ray scattering [SAXS]. By contrast, CKD reduced work to fracture and variation in bone tissue modulus and composition (Raman spectroscopy), and increased percent collagen strain. The increased collagen strain burden was associated with loss of toughness in CKD. In addition, osteocyte lacunae became smaller, sparser, and more disordered with age for Sham mice, yet these age-related changes were not clearly observed in CKD. However, for CKD, larger lacunae positively correlated with increased serum phosphate levels, suggesting that osteocytes play a role in systemic mineral homeostasis. This work demonstrates that CKD reduces bone quality, including microarchitecture and bone material properties, and that loss of bone quality with age is compounded by CKD. These findings may help reconcile why bone mass does not consistently predict fracture in the CKD population, as well as why older individuals with CKD are at high risk of fragility.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aging; Bone fragility; Bone quality; CKD; Collagen

Mesh:

Substances:

Year:  2019        PMID: 31055118      PMCID: PMC6760860          DOI: 10.1016/j.bone.2019.04.019

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  49 in total

1.  The relationship between the stiffness and the mineral content of bone.

Authors:  J D Currey
Journal:  J Biomech       Date:  1969-10       Impact factor: 2.712

2.  The compositional and physicochemical homogeneity of male femoral cortex increases after the sixth decade.

Authors:  Janardhan S Yerramshetty; Cora Lind; Ozan Akkus
Journal:  Bone       Date:  2006-07-21       Impact factor: 4.398

Review 3.  Bone quality--the material and structural basis of bone strength and fragility.

Authors:  Ego Seeman; Pierre D Delmas
Journal:  N Engl J Med       Date:  2006-05-25       Impact factor: 91.245

4.  Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  S Moe; T Drüeke; J Cunningham; W Goodman; K Martin; K Olgaard; S Ott; S Sprague; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

5.  Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN/Kob rats.

Authors:  M Saito; K Fujii; Y Mori; K Marumo
Journal:  Osteoporos Int       Date:  2006-06-13       Impact factor: 4.507

6.  Age-related effect on the concentration of collagen crosslinks in human osteonal and interstitial bone tissue.

Authors:  Jeffry S Nyman; Anuradha Roy; Rae L Acuna; Heather J Gayle; Michael J Reyes; Jerrod H Tyler; David D Dean; Xiaodu Wang
Journal:  Bone       Date:  2006-09-08       Impact factor: 4.398

7.  Relationship between moderate to severe kidney disease and hip fracture in the United States.

Authors:  Thomas L Nickolas; Donald J McMahon; Elizabeth Shane
Journal:  J Am Soc Nephrol       Date:  2006-09-27       Impact factor: 10.121

8.  Bone development and age-related bone loss in male C57BL/6J mice.

Authors:  Virginia L Ferguson; Reed A Ayers; Ted A Bateman; Steven J Simske
Journal:  Bone       Date:  2003-09       Impact factor: 4.398

9.  Changes in bone structure and mass with advancing age in the male C57BL/6J mouse.

Authors:  Bernard P Halloran; Virginia L Ferguson; Steven J Simske; Andrew Burghardt; Laura L Venton; Sharmila Majumdar
Journal:  J Bone Miner Res       Date:  2002-06       Impact factor: 6.741

10.  Age-related changes in the collagen network and toughness of bone.

Authors:  X Wang; X Shen; X Li; C Mauli Agrawal
Journal:  Bone       Date:  2002-07       Impact factor: 4.398

View more
  16 in total

1.  Perilacunar bone tissue exhibits sub-micrometer modulus gradation which depends on the recency of osteocyte bone formation in both young adult and early-old-age female C57Bl/6 mice.

Authors:  Caleb J Rux; Ghazal Vahidi; Amir Darabi; Lewis M Cox; Chelsea M Heveran
Journal:  Bone       Date:  2022-01-11       Impact factor: 4.398

2.  The combination of aging and chronic kidney disease leads to an exacerbated cortical porosity phenotype.

Authors:  Samantha P Tippen; Corinne E Metzger; Elizabeth A Swallow; Spencer A Sacks; Joseph M Wallace; Matthew R Allen
Journal:  Bone       Date:  2021-10-05       Impact factor: 4.398

Review 3.  Poor bone matrix quality: What can be done about it?

Authors:  Asier Muñoz; Anxhela Docaj; Maialen Ugarteburu; Alessandra Carriero
Journal:  Curr Osteoporos Rep       Date:  2021-08-20       Impact factor: 5.096

4.  Elevations in Cortical Porosity Occur Prior to Significant Rise in Serum Parathyroid Hormone in Young Female Mice with Adenine-Induced CKD.

Authors:  Corinne E Metzger; Elizabeth A Swallow; Matthew R Allen
Journal:  Calcif Tissue Int       Date:  2019-12-12       Impact factor: 4.333

5.  The age-related decrease in material properties of BALB/c mouse long bones involves alterations to the extracellular matrix.

Authors:  Amy Creecy; Sasidhar Uppuganti; Madeline R Girard; Siegfried G Schlunk; Chidi Amah; Mathilde Granke; Mustafa Unal; Mark D Does; Jeffry S Nyman
Journal:  Bone       Date:  2019-10-31       Impact factor: 4.398

6.  Enhanced Klotho availability protects against cardiac dysfunction induced by uraemic cardiomyopathy by regulating Ca2+ handling.

Authors:  José Alberto Navarro-García; Angélica Rueda; Tatiana Romero-García; Jennifer Aceves-Ripoll; Elena Rodríguez-Sánchez; Laura González-Lafuente; Carlos Zaragoza; María Fernández-Velasco; Makoto Kuro-O; Luis M Ruilope; Gema Ruiz-Hurtado
Journal:  Br J Pharmacol       Date:  2020-09-15       Impact factor: 8.739

Review 7.  Mechanobiology of Bone Metastatic Cancer.

Authors:  Blayne A Sarazin; Claire L Ihle; Philip Owens; Maureen E Lynch
Journal:  Curr Osteoporos Rep       Date:  2021-11-03       Impact factor: 5.096

8.  Bone turnover correlates with bone quantity but not bone microarchitecture in chronic hemodialysis.

Authors:  Roxana Dusceac; Dan Alexandru Niculescu; Ramona Dobre; Madalina Cristina Sorohan; Andra Caragheorgheopol; Catalin Tacu; Cristiana David; Catalina Poiana
Journal:  J Bone Miner Metab       Date:  2020-03-06       Impact factor: 2.626

9.  Bone biomechanical properties and tissue-scale bone quality in a genetic mouse model of familial dysautonomia.

Authors:  G Vahidi; H Flook; V Sherk; M Mergy; F Lefcort; C M Heveran
Journal:  Osteoporos Int       Date:  2021-05-25       Impact factor: 4.507

10.  Disrupted osteocyte connectivity and pericellular fluid flow in bone with aging and defective TGF-β signaling.

Authors:  Charles A Schurman; Stefaan W Verbruggen; Tamara Alliston
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.